Back to search

Article

Genetic Polymorphisms <em>CYP3A4*22</em>, <em>CYP3A5*3</em>, and CYP2D6 Predicted Phenotype are not Associated with Antipsychotic Treatment Outcomes in Neurotypical Prepubertal Boys with Conduct Disorders

2026-08-17

Abstract excerpt

<h4>Objectives: </h4> To identify associations between CYP3A4*22 CYP3A5*3 genotypes, CYP2D6 phenotype and the effectiveness and safety of antipsychotics in neurotypically developed boys with conduct disorders. <h4>Methods:</h4> The study included neurotypically developed boys aged 7–12 years who were hospitalized for conduct disorders. All patients were prescribed an antipsychotic. Patient follow-up lasted 14 days...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c018627a-19bb-51c8-8b9e-1c99c0fd2394
DOI
10.20944/preprints202608.1096.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genetic Polymorphisms <em>CYP3A4*22</em>, <em>CYP3A5*3</em>, and CYP2D6 Predicted Phenotype are not Associated with Antipsychotic Treatment Outcomes in Neurotypical Prepubertal Boys with Conduct DisordersDOI 10.20944/preprints202608.1096.v1
CYP450 2D6 and 2C19 genotypes in ADHD: not related with treatment resistance but with over-representation of 2C19 ultra-metabolizers.Semantic proximity
CYP2D6 Genotyping and Antipsychotic-Associated Extrapyramidal Adverse Effects in a Randomized Trial of Aripiprazole Versus Quetiapine Extended Release in Children and Adolescents, Aged 12-17 Years, With First Episode Psychosis.Semantic proximity
CYP2D6 phenotype and ABCB1 haplotypes are associated with antipsychotic safety in adolescents experiencing acute psychotic episodes.Semantic proximity
Evidence for Pharmacogenomic Effects on Risperidone Outcomes in Pediatrics.Semantic proximity
Drug-metabolizing enzyme genotypes and aggressive behavior treatment response in hospitalized pediatric psychiatric patients.Semantic proximity
Pharmacogenetics of antipsychotics in adolescents with acute psychotic episode during first 14 days after admission: effectiveness and safety evaluation.Semantic proximity
The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions.Semantic proximity
Neuroleptic malignant syndrome in an adolescent with CYP2D6 deficiency.Semantic proximity
Pharmacogenetic Factors Influence Escitalopram Pharmacokinetics and Adverse Events in Youth with a Family History of Bipolar Disorder: A Preliminary Study.Semantic proximity
The effect of CYP2D6 variation on antipsychotic-induced hyperprolactinaemia: a systematic review and meta-analysis.Semantic proximity
Pharmacogenetics to Predict Adverse Events Associated With Antidepressants.Semantic proximity
Impact of CYP2D6 Genotype and Inhibitor Use on Risperidone Metabolism in Children: Functional Insights Into the *17 and *29 Alleles.Semantic proximity
Select a neighboring publication to make it the new centre.